Karyopharm Therapeutics, Inc. (KPTI)
6.44
+0.05
(+0.78%)
USD |
NASDAQ |
Dec 10, 16:00
6.44
0.00 (0.00%)
After-Hours: 17:02
Karyopharm Therapeutics Total Assets (Quarterly): 96.23M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 1.025B |
| Actinium Pharmaceuticals, Inc. | 56.15M |
| Axsome Therapeutics, Inc. | 669.25M |
| Krystal Biotech, Inc. | 1.240B |
| Akebia Therapeutics, Inc. | 364.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 365.49M |
| Shareholders Equity (Quarterly) | -269.26M |
| Debt to Equity Ratio | -0.7295 |
| Current Ratio | 1.030 |
| Net Debt Paydown Yield | -0.28% |